Top Markets
Coin of the day
Millendo Therapeutics, Inc. Millendo Therapeutics, Inc.

Millendo Therapeutics, Inc.

MLND
Rank in Stocks #40617
Millendo Therapeutics, Inc. is an advanced biopharmaceutical firm dedicated to... Millendo Therapeutics, Inc. is an advanced biopharmaceutical firm dedicated to developing innovative therapies for rare hormonal disorders, primarily within the United States. The company's key therapeutic candidates include livoletide, an investigational drug aimed at Prader-Willi syndrome; nevanimibe, an experimental compound designed for patients with classic congenital adrenal hyperplasia; and MLE-301, a neurokinin 3-receptor antagonist intended to alleviate vasomotor symptoms (such as hot flashes) in women experiencing menopause. This enterprise maintains its primary operational base in Ann Arbor, Michigan.
Share Price
$1.06
Last synced: 2021-06-25
Market Cap
$110.93K
Change (1 day)
-5.36%
Change (1 year)
0.00%
Country
US
Trade Millendo Therapeutics, Inc. (MLND)

Category

Dividend yield history for Millendo Therapeutics, Inc. (MLND)
Millendo Therapeutics, Inc. (stock symbol: MLND) dividend yield (TTM) as of 2026: 0
Average dividend yield, last 5 years : 0.00%
Dividend yield history for Millendo Therapeutics, Inc. (MLND) from 2026 to 2026
Dividend Yield at the end of each year (TTM)
Year Dividend Yield Change
Not enough data for the provided dates.
Dividend yields (TTM) for similar companies or competitors